ArticleScientific reports2026
Genetic analyses of autoimmune mutants uncover the MPK3/6-CHR5-SNC1 module in Arabidopsis.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Role of cell wall-associated kinases in plant development and defense responses.Molecular biology reports · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Plant defense largely relies on an immune system that is induced by the binding of microbe-derived molecules to receptors at the plasma membrane, initiating the pattern-triggered immunity (PTI), and by the detection of pathogen effectors by intracellular nucleotide-binding leucine-rich repeat receptors (NLRs), eliciting the effector-triggered immunity (ETI). While PTI and ETI were initially thought to be independent, recent studies have revealed some interplay. Our group notably showed that the activity of mitogen-activated protein kinase 3 (MPK3) and MPK6 could link PTI and ETI responses by positively regulating the salicylic acid (SA)-dependent defense, through the up-regulation of some NLR genes. Here, we gained a better understanding of the relationship between these MAPKs and the key NLR suppressor of npr1-1, constitutive 1 (SNC1). By genetic analyses, we demonstrate that chromatin remodeling 5 (CHR5), a positive regulator of SNC1 expression, is downstream of MPK3 activity. We also provide evidence that CHR5 itself does not regulate immune MAPKs. We then show that plants expressing both MPK3 and SNC1 gain-of-function proteins synergistically exhibit a strong autoimmune phenotype. Finally, we report that MPK3 and MPK6 function redundantly upstream of SNC1. Overall, our results identified the MPK3/6-CHR5-SNC1 module, further refining the connection between PTI and ETI components.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.